Cargando…

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients

SIMPLE SUMMARY: Acute myeloid leukemia is an aggressive cancer in children and novel therapeutic tools are warranted to improve outcomes and reduce late effects in these patients. In this study, we isolate and explore the protein profiles of leukemic stem cells and normal hematopoietic stem cells fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersen, Marianne Agerlund, Rosenberg, Carina Agerbo, Bill, Marie, Enemark, Marie Beck, Rahbek, Ole, Roug, Anne Stidsholt, Hasle, Henrik, Honoré, Bent, Ludvigsen, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332109/ https://www.ncbi.nlm.nih.gov/pubmed/35892824 http://dx.doi.org/10.3390/cancers14153567

Ejemplares similares

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
por: Ludvigsen, Maja, et al.
Publicado: (2021)

Proteomic Analysis of Tissue from α1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2013)

PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
por: Beck Enemark, Marie, et al.
Publicado: (2021)

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
por: Enemark, Marie Beck, et al.
Publicado: (2022)

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
por: Ludvigsen, Maja, et al.
Publicado: (2020)

Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009)

A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia
por: Toft-Petersen, Marie, et al.
Publicado: (2014)

A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia
por: Kjeldsen, Eigil, et al.
Publicado: (2012)

IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients
por: Enemark, Marie Beck Hairing, et al.
Publicado: (2023)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
por: Jensen, Oda, et al.
Publicado: (2022)

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A‐related cancer stem cell biology
por: Bill, Marie, et al.
Publicado: (2018)

Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers
por: Christensen, Britt, et al.
Publicado: (2015)

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
por: Honoré, Bent, et al.
Publicado: (2022)

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome
por: Toft‐Petersen, Marie, et al.
Publicado: (2016)

Severe Peripheral Neuropathy From Treatment With Arsenic Trioxide in a Patient Suffering From Acute Promyelocytic Leukemia
por: Helso, Soren Niemi, et al.
Publicado: (2020)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Low-dose salinomycin induces anti-leukemic responses in AML and MLL
por: Roulston, Gary D.R., et al.
Publicado: (2016)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
por: Haubner, S., et al.
Publicado: (2018)

β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells
por: Zhao, Xin, et al.
Publicado: (2020)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort
por: Herlin, Morten Krogh, et al.
Publicado: (2021)

Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
por: Zhang, Yongping, et al.
Publicado: (2023)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo
por: Neldeborg, Signe, et al.
Publicado: (2023)

High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma
por: Madsen, Charlotte, et al.
Publicado: (2019)

Glycolytic biomarkers predict transformation in patients with follicular lymphoma
por: Monrad, Ida, et al.
Publicado: (2020)

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
por: Bargal, Salma A., et al.
Publicado: (2018)

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
por: Vazquez, Romain, et al.
Publicado: (2021)

A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2017)

Type 2 diabetes mellitus worsens neurological injury following cardiac arrest: an animal experimental study
por: Vammen, Lauge, et al.
Publicado: (2018)

Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
por: Andersen, Morten Nørgaard, et al.
Publicado: (2017)

A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML
por: Lieske, Anna, et al.
Publicado: (2022)

Attempting to distinguish between endogenous and contaminating cytokeratins in a corneal proteomic study
por: Lyngholm, Mikkel, et al.
Publicado: (2011)

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML
por: Daga, Shruti, et al.
Publicado: (2019)

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML
por: Heudobler, Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n5lgo1lcbcaqfi5vtml3a2bdq1